Italian study tracks new antibody drugs for lymphoma patients
NCT ID NCT06008691
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 1,500 people with B-cell non-Hodgkin lymphoma in Italy who are treated with newer monoclonal antibodies. Researchers will track how well the cancer responds, how long patients live without the disease getting worse, and any side effects. The goal is to see how these drugs perform in everyday medical practice, not in a controlled experiment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2023
- Expected to finish
-
Oct 2038
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with diagnosis of B-cell NHL both first-line and relapsed or refractory aimed to be treated in indication with a "novel" MAB (alone or in combination) based on presence of an EMA clinical indication since 2020 and prescribed according to the indications for use authorized for marketing in Italy.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with diagnosis of B-cell NHL and need of treatment (as per guideline indications), both first-line and relapsed or refractory. * Patients aimed to be treated in indication with a "novel" MAB (alone or in combination) based on presence of an EMA clinical indication since 2020 and prescribed according to the indications for use authorized for marketing in Italy. * Signed written informed consent. Exclusion Criteria: * Being involved in a prospective interventional trial outside indication. * Patients treated outside approved indications: * 648-approved indication. * 5% AIFA support. * Compassionate use. * Age less than 18 years. * Inability to provide an informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non-Hodgkin lymphoma, B-cell are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
61 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
A.O. C. Panico - U.O.C Ematologia e Trapianto
RECRUITINGTricase, Italy
-
A.O. Ospedali Riuniti Villa Sofia-Cervello - Divisione di Ematologia
NOT_YET_RECRUITINGPalermo, Italy
-
A.O. S. Croce e Carle - S.C. di Ematologia e Trapianto di Midollo Osseo
RECRUITINGCuneo, Italy
-
A.O. S. Maria di Terni - S.C. Oncoematologia
NOT_YET_RECRUITINGTerni, Italy
-
A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia
RECRUITINGAlessandria, Italy
-
A.O.R. "San Carlo" - U.O. Ematologia
NOT_YET_RECRUITINGPotenza, Italy
-
A.O.U. Città della Salute e della Scienza di Torino - Ematologia Universitaria
RECRUITINGTorino, Italy
-
A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia
RECRUITINGTorino, Italy
-
AO Sant' Andrea - Ematologia
RECRUITINGRoma, Italy
-
AOU Federico II - Ematologia
NOT_YET_RECRUITINGNaples, Italy
-
AOU Integrata di Verona - U.O. Ematologia
RECRUITINGVerona, Italy
-
AOU Maggiore della Carità di Novara - SCDU Ematologia
RECRUITINGNovara, Italy
-
AOU Ospedali Riuniti - Clinica di Ematologia
RECRUITINGAncona, Italy
-
AOU Senese - U.O.C. Ematologia
RECRUITINGSiena, Italy
-
AOU di Sassari - Ematologia
NOT_YET_RECRUITINGSassari, Italy
-
ASST Cremona - Ematologia e CRTO
RECRUITINGCremona, Italy
-
ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia
RECRUITINGMilan, Italy
-
ASST Santi Paolo e Carlo - Onco - Ematologia
RECRUITINGMilan, Italy
-
ASST Spedali Civili di Brescia - Ematologia
RECRUITINGBrescia, Italy
-
Arnas Nuovo Ospedale Garibaldi Nesima - U.O.C. Ematologia
RECRUITINGCatania, Italy
-
Azienda Ospedaliera Papa Giovanni XXIII - Ematologia
RECRUITINGBergamo, Italy
-
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
RECRUITINGAvellino, Italy
-
Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia
RECRUITINGFlorence, Italy
-
Azienda Ospedaliera Universitaria Policlinico - S. Marco - UOC di Emtologia
RECRUITINGCatania, Italy
-
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) - SOC Clinica Ematologica
RECRUITINGUdine, Italy
-
Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia
RECRUITINGTrieste, Italy
-
Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia
RECRUITINGReggio Emilia, Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Ematologia
RECRUITINGMilan, Italy
-
Fondazione IRCCS San Gerardo dei Tintori - Ematologia
RECRUITINGMonza, Italy
-
Fondazione del Piemonte per l'Oncologia - IRCCS - Ematologia
RECRUITINGCandiolo, Italy
-
I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1
RECRUITINGPadova, Italy
-
IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati
RECRUITINGAviano, Italy
-
IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia
RECRUITINGBari, Italy
-
IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia
NOT_YET_RECRUITINGPavia, Italy
-
IRCCS-Centro di Riferimento Oncologico - UO di ematologia e Trapianto Cellule Staminali
RECRUITINGRionero in Vulture, Italy
-
Istituto Clinico Humanitas - U.O. Ematologia
RECRUITINGRozzano, Italy
-
Istituto Oncologico del Mediterraneo SPA - Oncologico
NOT_YET_RECRUITINGViagrande, Catania, Italy
-
Istituto Scientifico San Raffaele - Unità Linfomi - Dipartimento Oncoematologia
RECRUITINGMilan, Italy
-
Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico
RECRUITINGSassuolo, Italy
-
Nuovo Ospedale degli Infermi - SSD Ematologia
RECRUITINGBiella, Italy
-
Osp. civile di Carrara - Oncologia Medica
RECRUITINGCarrara, Italy
-
Ospedale "G. Mazzini" - UOS Ematologia
NOT_YET_RECRUITINGTeramo, Italy
-
Ospedale "Monsignor Raffaele Dimiccoli" - Ematologia
NOT_YET_RECRUITINGBarletta, Italy
-
Ospedale Apuane - Oncoematologia
RECRUITINGMassa, Italy
-
Ospedale Businco - SC Ematologia e CTMO
NOT_YET_RECRUITINGCagliari, Italy
-
Ospedale Ca' Foncello - S.C di Ematologia
RECRUITINGTreviso, Italy
-
Ospedale Guglielmo da Saliceto - U.O. Ematologia
RECRUITINGPiacenza, Italy
-
Ospedale S.Stefano SOS Oncoematologia
RECRUITINGPrato, Italy
-
Ospedale SS. Cosma e Damiano - Ospedale San Jacopo - SOS Oncoematologia ed ematologia clinica
RECRUITINGPescia, Pistoia, Italy
-
Ospedale Versilia USL NORDOVEST Toscana - UOS Ematologia
RECRUITINGLido di Camaiore, Italy
-
Ospedale delle Croci - Ematologia
RECRUITINGRavenna, Italy
-
Ospedale di Castelfranco Veneto - Ematologia
RECRUITINGCastelfranco Veneto, Italy
-
Ospedale di Civitanova Marche - UOSD EMATOLOGIA AREA VASTA 3 MACERATA
RECRUITINGCivitanova Marche, Italy
-
Ospedale di Livorno - Ematologia
RECRUITINGLivorno, Italy
-
P.O. Spirito Santo di Pescara - UOS Dipartimentale - Centro di diagnosi e Terapia dei linfomi
RECRUITINGPescara, Italy
-
Policlinico S. Orsola-Malpighi - Istituto di Ematologia "Seragnoli"
RECRUITINGBologna, Italy
-
Policlinico Umberto I - Università "La Sapienza" - Istituto Ematologia -Dipartimento di Medicina Traslazionale e di Precisione
RECRUITINGRoma, Italy
-
Policlinico Universitario Campus Bio-Medico - Ematologia - Trapianto cellule staminali - Medicina Trasfusionale e Terapia cellulare
RECRUITINGRoma, Italy
-
Presidio Ospedaliero F. Spaziani - UOC Ematologia
RECRUITINGFrosinone, Italy
-
Presidio ospedaliero "A. TORTORA" - U.O. Onco-ematologia
NOT_YET_RECRUITINGPagani, Italy
-
ULSS 8 Berica - Ospedale S. Bortolo - Ematologia
RECRUITINGVicenza, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immune cell therapy outsmart resistant blood cancers?
- Engineered immune cells take on tough blood cancers
- Lymphoma Patients' vaccine response under scrutiny
- Muscle loss may predict CAR-T outcomes in lymphoma
- New CAR-T therapy targets Hard-to-Treat lymphoma
- Off-the-Shelf cell therapy takes on tough lymphoma